Free Shipping for Orders Over $100!

Boluoke Lumbrokinase by Canada RNA - 120 capsules Oral Supplement Canada RNA
Boluoke Lumbrokinase by Canada RNA - 120 capsules Oral Supplement Canada RNA
Boluoke Lumbrokinase by Canada RNA - 120 capsules Oral Supplement Canada RNA
Boluoke® Lumbrokinase | RNA Supplement - 60 or 120 capsules Oral Supplement Canada RNA 60 Capsules
Boluoke® Lumbrokinase | RNA Supplement - 60 or 120 capsules Oral Supplement Canada RNA

Practitioner Selected Product

Boluoke® Lumbrokinase | RNA Supplement - 60 or 120 capsules

Vendor
Canada RNA
Regular price
$167.98
Sale price
$167.98
Shipping calculated at checkout.
Quantity must be 1 or more

Practitioner Selected Product

Boluoke® (lumbrokinase) is an extensively researched oral enzyme that shows encouraging results for supporting healthy coagulation/fibrinolysis in the body.*

Boluoke® may assist people with a tendency towards hypercoagulation, by reducing fibrinogen and fibrin without interfering with the clotting cascade.* Boluoke® does not impact INR or aPTT, and is therefore compatible with Coumadin® or heparin.

Lumbrokinase is more potent than other enzymes on the market, including nattokinase. Boluoke® lumbrokinase is of superior quality, standardized against urokinase and t-PA, unlike other products. 

When selecting a lumbrokinase product, it’s crucial to compare the amount of active lumbrokinase per capsule, not capsule weight. Boluoke®’s capsules are 200mg, and contain 20mg of active lumbrokinase inside each capsule. It’s unlikely you’ll find another product that specifies the active ingredient and matches this ratio.

Although earthworm extract has become more commonly available, most imitations contains very little pure lumbrokinase.

Boluoke® Research

Boluoke® is the only extensively researched oral fibrinolytic supplement available. Research has included in vitro (outside the body), animal studies, toxicity studies and pharmacokinetic studies. In addition, Boluoke® has been assessed via all phases of clinical trial in China and is now used in hospitals in China, as well as being covered by the Chinese National Fundamental Health Insurance. 

Are there any side effects?

A trial involving 16 hospitals and 1560 patients in China reported no hemorrhage or major side effects. In terms of minor adverse effects, 0.19% of participants experienced a skin rash, 1.15% nausea or diarrhea, and 0.58% skin itching, with an overall adverse reaction rate of 1.92%. This research specifically applies to Boluoke® and cannot be applied to other products on the market, despite the claims.

*These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any diseases.

Ingredients

Ingredients

Proprietary earthworm protein extract ~20 mg (Boluoke® lumbrokinase 300,000u)

Other ingredients: acid-resistant hypromellose capsules, microcrystalline cellulose


Serving size: 1 capsule

Servings per container: 120

 

Directions

Directions

1-2 capsules one to three times daily on an empty stomach, or as directed by a healthcare practitioner.

Caution: Consult your physician prior to use if you are pregnant, breastfeeding, taking antiplatelets, or taking anticoagulants. People with a known bleeding tendency or known allergy to earthworms should not take this product.

FAQs

 How long before surgery should patient stop taking Boluoke®?
The conservative approach is to stop Boluoke® 1 week prior to surgery. The patient may resume taking Boluoke® 15 days after surgery if no complication or earlier if the physician deems appropriate. Some physicians do recommend patients to stay on a small dose of Boluoke? post surgery in certain high-risk patients.

Can Boluoke® be safely taken if the patient is on blood thinning agents?
Lumbrokinase has been safely used together with blood thinning agents in various clinical studies, and does not have any adverse interaction nor increase the chance of bleeding other than what is inherent to the blood thinners (Park S, Kye KC, Sumi H, et al. 1989). Boluoke® has been shown not to significantly affect PT and aPTT (thus it does not affect INR). However, patients should always consult their physicians before taking Boluoke® while on any prescriptions.

Can the content of Boluoke® capsules be emptied out and taken without the capsules?
The capsules used in Boluoke® are enteric coated capsules. They are designed to resist stomach acid and dissolve in the small intestines, because lumbrokinase may be inactivated by stomach acid. Preliminary coagulation tests using Sonoclot® machine (manufactured by Sienco, Inc.) indicate that Boluoke® is still effective when taken without the capsules on an empty stomach. However, it is highly recommended that the patients take Boluoke® in its original capsulated format whenever possible.

Can Boluoke® be safely taken with anti-platelet agents?
There has been no study specifically looking at this; there has also been no report of adverse interactions to date. However, because Boluoke® can affect platelet aggregation (Zhang GP, Qian RZ, et al. 1998), it should not be used with strong anti-platelets like Plavix or Ticlid unless under the supervision of a physician.

Can Boluoke® be safely taken with aspirin?
Boluoke® has been shown to be safe when taken with aspirin in clinical studies (Wang XL, Yan DC. 2000; Wang H, Yan DC, et al. 2000). However, patients should consult with their physicians before taking Boluoke® with aspirin or other NSAIDs.

Can Boluoke® be used on pregnant women?
Teratogenicity studies of Boluoke® on animals showed no effect on pregnancy weight, fetal growth, abortion rate, still birth rate, and fetal resorption rate in mice compared to the placebo group. There was also no birth defect detected. However, pregnant patients should not take Boluoke® unless it is done under a physician’s approval and supervision.

What are the contra-indications for taking Boluoke®?
Contra-indications for Boluoke® are: allergy to lumbrokinase or earthworm; recent surgery; pre-surgery; lumbar puncture or arterial puncture; trauma; high risk aneurysm; active internal bleeding or GI ulceration; any other bleeding disorders/tendencies. People who are taking any anti-coagulants (e.g. heparin, coumadin) or anti-platelet drugs (e.g. Plavix or Ticlid) should consult their physicians before taking Boluoke.

Does Boluoke® have any side effects?
The earthworm has been used in Traditional Chinese Medicine for a few thousand years, and is considered to be one of the safest medicines in the traditional pharmacopoeias. In one of the largest clinic trial of Boluoke® involving 16 hospitals and 1560 patients in China, the overall adverse reaction rate was 1.92% (30 cases). 0.58% had skin itching, 0.19% had skin rash, and 1.15% had nausea or diarrhea; no hemorrhage or major side effect was reported.

Can Boluoke® be taken with other enzyme products?
There is a theoretical possibility that Boluoke® may be cleaved and rendered ineffective by other proteolytic enzymes, so we currently do not recommend dosing Boluoke® with another proteolytic enzyme product. If you do have to take other such enzyme products while on Boluoke®, try to space more time between the dosing of the two enzyme products (i.e. at least 2 hours).

What about uterine fibroids, is Boluoke® useful?
Again, this is another myth that’s been propagated on the Internet and it is equally without merit. Boluoke® is not likely to help those patients.

Can Boluoke® be used to replace Coumadin®?
Boluoke® is a nutraceutical product and should not be used to replace Coumadin®. However, if patients refuse to take Coumadin® as recommended, then the physician shall find the best alternatives for the patients. Regardless what alternatives the physician decides on, the patients should be properly monitored. If Boluoke® was chosen as the best alternative, the patients should be checked for anti-plasmin, prothrombin fragment 1+2, thrombin/antithrombin complex, or soluble fibrin monomer to make sure that patients are well protected. A discussion with specialized hematology lab as to what might be the best way to monitor patient status is highly recommended.

What is the suggested protocol for taking Boluoke®?
Boluoke® is best taken under a physician’s guidance in accordance to the patient’s individual condition. For most chronic conditions and maintenance, 1 capsule once to three times daily on empty stomach should be sufficient. In acute conditions Boluoke® can be taken at the dose of 2 capsules three times daily on an empty stomach for 3 to 6 weeks or as long as the doctor recommends.

What kind of tests can be used to see if patients are on appropriate doses of Boluoke®?
Tests like anti-plasmin, prothrombin fragment 1+2, thrombin/antithrombin complex, or soluble fibrin monomer levels are some possible tests to help physician determine if patients are on appropriate doses of Boluoke®. We have also found that the gbACT+ test performed on Sonoclot® machine (manufactured by Sienco, Inc.) is a very helpful tool for in-office monitoring of patient status. However, a discussion with specialized hematology lab as to what might be the best way to monitor patient status is highly recommended.

How is Boluoke® different from other products that contain lumbrokinase?
Boluoke® is the only lumbrokinase that has been through all phases of clinical trials and its enzymatic strength is standardized against tPA and urokinase activities. Other lumbrokinase products currently on the market often are citing Boluoke®’s credentials and research, and are not disclosing the enzymatic strength of their lumbrokinase. On the raw material market, the price of lumbrokinase can vary by up to 15 fold, and the enzymatic strengths of various lumbrokinase also differ greatly. In addition, lumbrokinase is a preparation containing multiple enzyme fractions, and the extraction and purification method determines the composition of the various enzyme fractions. Thus different extraction method will produce different sub-fractions of lumbrokinase. This is the reason why Boluoke® does not significantly change prothrombin time (PT) or activated partial thromboplastin time (aPTT), while other lumbrokinase sources may significantly alter PT or aPTT as shown in some studies (Jin L, Jin H, Zhang G, Xu G. 2000).

Does lumbrokinase interfere with Vitamin K?
Lumbrokinase is not an anti-coagulant and does not interfere with the clotting cascade (like warfarin or heparin), thus is it compatible with Vitamin K.

Is the product GMO-free?
Yes, Boluoke is GMO-free.